Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer

被引:3
|
作者
Yoshiji, H
Gomez, DE
Shibuya, M
Thorgeirsson, UP
机构
[1] NCI,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,TUMOR BIOL & CARCINOGENESIS SECT,DIV BASIC SCI,BETHESDA,MD 20892
[2] UNIV TOKYO,INST MED SCI,DEPT GENET,MINATO KU,TOKYO 108,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is essential for the growth and metastasis of solid tumors, In this study, we examined gene expression of vascular endothelial growth factor (VEGF); its receptor, flt-1; basic fibroblast growth factor; and transforming growth factors (TGFs) alpha and beta in 18 paired cases of human breast carcinomas and the adjacent nonneoplastic tissues, In all of the paired cases, VEGF expression was markedly increased in the carcinomas, In contrast, an insignificant difference was observed in the expression of flt-1, basic fibroblast growth factor, TGF-alpha, and TGF-beta between the malignant breast tissue and the nonneoplastic counterpart. Immunostaining showed variable VEGF positivity of the malignant cells, whereas the nonneoplastic breast epithelial cells were negative, The findings of this study suggest that VEGF is an important angiogenic factor in human breast cancer.
引用
收藏
页码:2013 / 2016
页数:4
相关论文
共 50 条
  • [1] Vascular Endothelial Growth Factor Receptor-1 Expression in Breast Cancer and Its Correlation to Vascular Endothelial Growth Factor A
    Srabovic, Nahida
    Mujagic, Zlata
    Mujanovic-Mustedanagic, Jasminka
    Softic, Adaleta
    Muminovic, Zdeno
    Rifatbegovic, Adi
    Begic, Lejla
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [2] Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
    Anan, K
    Morisaki, T
    Katano, M
    Ikubo, A
    Kitsuki, H
    Uchiyama, A
    Kuroki, S
    Tanaka, M
    Torisu, M
    SURGERY, 1996, 119 (03) : 333 - 339
  • [3] Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
    Fujimoto, K
    Hosotani, R
    Wada, M
    Lee, JU
    Koshiba, T
    Miyamoto, Y
    Tsuji, S
    Nakajima, S
    Doi, R
    Imamura, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (09) : 1439 - 1447
  • [5] Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary
    Reynolds, LP
    Redmer, DA
    JOURNAL OF ANIMAL SCIENCE, 1998, 76 (06) : 1671 - 1681
  • [6] An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1
    Elkin, M
    Orgel, A
    Kleinman, HK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11): : 875 - 878
  • [7] Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy
    Veeravagu, Anand
    Hsu, Andrew R.
    Cai, Weibo
    Hou, Lewis C.
    Tse, Victor C. K.
    Chen, Xiaoyuan
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (01) : 59 - 71
  • [8] Expression of vascular endothelial growth factor (VEGF) associated with its receptor (VEGFR) in relation to tissue factor (TF) in human breast cancer tissue
    Wojtukiewicz, M
    Sierko, E
    Zimnoch, L
    Thorpe, P
    Brekken, RA
    Kisiel, W
    BLOOD, 2005, 106 (11) : 86B - 86B
  • [9] Expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer
    Kranz, A
    Mattfeldt, T
    Waltenberger, J
    JOURNAL OF VASCULAR RESEARCH, 1999, 36 (02) : 185 - 185
  • [10] Expression of keratinocyte growth factor and its receptor in human breast cancer
    Bansal, GS
    Cox, HC
    Marsh, S
    Gomm, J
    Yiangou, C
    Luqmani, Y
    Coombes, RC
    Johnston, CL
    BRITISH JOURNAL OF CANCER, 1997, 75 (11) : 1567 - 1574